E Merck (India) (MERCK) was incorporated in 1967 to take over the business of the Indian branch of Emeda Exports with all its assets and liabilities. The company is a 51% subsidiary of Merck KGaA, Germany, a player in vitamin formulations. MERCK has five divisions - pharma, reagents, bulk drugs, diagnostics and pigments. The products manufactured are specialities in the group of neurotropics, dermatology, antibiotics, nasal decongestants, basic vitamins, imaging agents, laboratory and fine chemicals, etc. E-Merck started operations as a manufacturer of pharmaceutical specialities and over the years, it has diversified its product range to include basic drugs, fine and industrial chemicals, and diagnostics. The product mix of MERCK includes Cod polybion syrup, Pedimune - P, Osto Polybion syrup, Flexi joint capsules, Livogen drops, Concor AM 2.5 TABS, Concor AM 5 TABS etc. E Merck (India) is gradually increasing its presence in cardiovascular, anti-infectives and anti-malarial segments to widen its therapeutic reach. The investing associates of E-Merck include Chemitra GmbH, Germany, Emedia Export Company, Germany and Merck Internationale Beteiligungen GmbH, Germany and has Chemische Fabrik Lehre, Germany, EMD Biosciences Inc., U.S.A. Merck B Cie KG, Switzerland Seven Seas, U. K. P. T. Merck Indonesia et al as its subsidiaries. Life Science and Analytics (excluding Bulk Drugs) Business, which formed part of the Chemicals segment was sold with effect from April 1, 2006. MERCK proposes to make efforts to develop innovative, commercially viable processes know-how for both active pharmaceutical ingredients and dosage forms and also for improving the shelf life/stability, quality, convenience, meeting regulatory compliances, continuous RED initiatives. E Merck (India) is located at Mumbai, India.
Note : Merck Ltd renamed as Procter & Gamble Health Ltd "The company has received approval from the Registrar of Companies, Mumbai, Maharashtra, for change of name from Merck Ltd to Procter & Gamble Health Ltd effective May 6, 2019," Merck said in a filing to the BSE
You
should Trade Less But Trade Accurately & this is Achieved with our Tip.
